These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 34020817)
1. A non-affinity purification process for GMP production of prefusion-closed HIV-1 envelope trimers from clades A and C for clinical evaluation. Gulla K; Cibelli N; Cooper JW; Fuller HC; Schneiderman Z; Witter S; Zhang Y; Changela A; Geng H; Hatcher C; Narpala S; Tsybovsky Y; Zhang B; Vrc Production Program ; McDermott AB; Kwong PD; Gowetski DB Vaccine; 2021 Jun; 39(25):3379-3387. PubMed ID: 34020817 [TBL] [Abstract][Full Text] [Related]
2. Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity. Chuang GY; Geng H; Pancera M; Xu K; Cheng C; Acharya P; Chambers M; Druz A; Tsybovsky Y; Wanninger TG; Yang Y; Doria-Rose NA; Georgiev IS; Gorman J; Joyce MG; O'Dell S; Zhou T; McDermott AB; Mascola JR; Kwong PD J Virol; 2017 May; 91(10):. PubMed ID: 28275193 [TBL] [Abstract][Full Text] [Related]
3. Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses. Chuang GY; Lai YT; Boyington JC; Cheng C; Geng H; Narpala S; Rawi R; Schmidt SD; Tsybovsky Y; Verardi R; Xu K; Yang Y; Zhang B; Chambers M; Changela A; Corrigan AR; Kong R; Olia AS; Ou L; Sarfo EK; Wang S; Wu W; Doria-Rose NA; McDermott AB; Mascola JR; Kwong PD J Virol; 2020 Jun; 94(13):. PubMed ID: 32295908 [TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody. Cheng C; Pancera M; Bossert A; Schmidt SD; Chen RE; Chen X; Druz A; Narpala S; Doria-Rose NA; McDermott AB; Kwong PD; Mascola JR J Virol; 2015 Dec; 90(6):2740-55. PubMed ID: 26719262 [TBL] [Abstract][Full Text] [Related]
6. A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene. Pugach P; Ozorowski G; Cupo A; Ringe R; Yasmeen A; de Val N; Derking R; Kim HJ; Korzun J; Golabek M; de Los Reyes K; Ketas TJ; Julien JP; Burton DR; Wilson IA; Sanders RW; Klasse PJ; Ward AB; Moore JP J Virol; 2015 Mar; 89(6):3380-95. PubMed ID: 25589637 [TBL] [Abstract][Full Text] [Related]
7. cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV-1 envelope glycoprotein vaccine candidate. Dey AK; Cupo A; Ozorowski G; Sharma VK; Behrens AJ; Go EP; Ketas TJ; Yasmeen A; Klasse PJ; Sayeed E; Desaire H; Crispin M; Wilson IA; Sanders RW; Hassell T; Ward AB; Moore JP Biotechnol Bioeng; 2018 Apr; 115(4):885-899. PubMed ID: 29150937 [TBL] [Abstract][Full Text] [Related]
8. SOS and IP Modifications Predominantly Affect the Yield but Not Other Properties of SOSIP.664 HIV-1 Env Glycoprotein Trimers. Ringe RP; Colin P; Torres JL; Yasmeen A; Lee WH; Cupo A; Ward AB; Klasse PJ; Moore JP J Virol; 2019 Dec; 94(1):. PubMed ID: 31619555 [TBL] [Abstract][Full Text] [Related]
9. Soluble Prefusion Closed DS-SOSIP.664-Env Trimers of Diverse HIV-1 Strains. Joyce MG; Georgiev IS; Yang Y; Druz A; Geng H; Chuang GY; Kwon YD; Pancera M; Rawi R; Sastry M; Stewart-Jones GBE; Zheng A; Zhou T; Choe M; Van Galen JG; Chen RE; Lees CR; Narpala S; Chambers M; Tsybovsky Y; Baxa U; McDermott AB; Mascola JR; Kwong PD Cell Rep; 2017 Dec; 21(10):2992-3002. PubMed ID: 29212041 [TBL] [Abstract][Full Text] [Related]
10. Stabilization of a soluble, native-like trimeric form of an efficiently cleaved Indian HIV-1 clade C envelope glycoprotein. Ahmed S; Shrivastava T; Kumar N; Ozorowski G; Ward AB; Chakrabarti BK J Biol Chem; 2017 May; 292(20):8236-8243. PubMed ID: 28283570 [TBL] [Abstract][Full Text] [Related]
11. Automated Design by Structure-Based Stabilization and Consensus Repair to Achieve Prefusion-Closed Envelope Trimers in a Wide Variety of HIV Strains. Rawi R; Rutten L; Lai YT; Olia AS; Blokland S; Juraszek J; Shen CH; Tsybovsky Y; Verardi R; Yang Y; Zhang B; Zhou T; Chuang GY; Kwong PD; Langedijk JPM Cell Rep; 2020 Nov; 33(8):108432. PubMed ID: 33238130 [TBL] [Abstract][Full Text] [Related]
12. Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers Ozorowski G; Cupo A; Golabek M; LoPiccolo M; Ketas TA; Cavallary M; Cottrell CA; Klasse PJ; Ward AB; Moore JP J Virol; 2018 Jul; 92(13):. PubMed ID: 29669838 [TBL] [Abstract][Full Text] [Related]
13. Design and structure of two HIV-1 clade C SOSIP.664 trimers that increase the arsenal of native-like Env immunogens. Julien JP; Lee JH; Ozorowski G; Hua Y; Torrents de la Peña A; de Taeye SW; Nieusma T; Cupo A; Yasmeen A; Golabek M; Pugach P; Klasse PJ; Moore JP; Sanders RW; Ward AB; Wilson IA Proc Natl Acad Sci U S A; 2015 Sep; 112(38):11947-52. PubMed ID: 26372963 [TBL] [Abstract][Full Text] [Related]
14. Conformational States of a Soluble, Uncleaved HIV-1 Envelope Trimer. Liu Y; Pan J; Cai Y; Grigorieff N; Harrison SC; Chen B J Virol; 2017 May; 91(10):. PubMed ID: 28250125 [TBL] [Abstract][Full Text] [Related]
15. Closing and Opening Holes in the Glycan Shield of HIV-1 Envelope Glycoprotein SOSIP Trimers Can Redirect the Neutralizing Antibody Response to the Newly Unmasked Epitopes. Ringe RP; Pugach P; Cottrell CA; LaBranche CC; Seabright GE; Ketas TJ; Ozorowski G; Kumar S; Schorcht A; van Gils MJ; Crispin M; Montefiori DC; Wilson IA; Ward AB; Sanders RW; Klasse PJ; Moore JP J Virol; 2019 Feb; 93(4):. PubMed ID: 30487280 [TBL] [Abstract][Full Text] [Related]
16. Epitope-Independent Purification of Native-Like Envelope Trimers from Diverse HIV-1 Isolates. Verkerke HP; Williams JA; Guttman M; Simonich CA; Liang Y; Filipavicius M; Hu SL; Overbaugh J; Lee KK J Virol; 2016 Oct; 90(20):9471-82. PubMed ID: 27512064 [TBL] [Abstract][Full Text] [Related]
17. Differential binding of neutralizing and non-neutralizing antibodies to native-like soluble HIV-1 Env trimers, uncleaved Env proteins, and monomeric subunits. Yasmeen A; Ringe R; Derking R; Cupo A; Julien JP; Burton DR; Ward AB; Wilson IA; Sanders RW; Moore JP; Klasse PJ Retrovirology; 2014 May; 11():41. PubMed ID: 24884783 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity in Rabbits of HIV-1 SOSIP Trimers from Clades A, B, and C, Given Individually, Sequentially, or in Combination. Torrents de la Peña A; de Taeye SW; Sliepen K; LaBranche CC; Burger JA; Schermer EE; Montefiori DC; Moore JP; Klasse PJ; Sanders RW J Virol; 2018 Apr; 92(8):. PubMed ID: 29367243 [TBL] [Abstract][Full Text] [Related]
19. Cleavage-Independent HIV-1 Trimers From CHO Cell Lines Elicit Robust Autologous Tier 2 Neutralizing Antibodies. Bale S; Martiné A; Wilson R; Behrens AJ; Le Fourn V; de Val N; Sharma SK; Tran K; Torres JL; Girod PA; Ward AB; Crispin M; Wyatt RT Front Immunol; 2018; 9():1116. PubMed ID: 29881382 [TBL] [Abstract][Full Text] [Related]
20. Influences on the Design and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers. Ringe RP; Yasmeen A; Ozorowski G; Go EP; Pritchard LK; Guttman M; Ketas TA; Cottrell CA; Wilson IA; Sanders RW; Cupo A; Crispin M; Lee KK; Desaire H; Ward AB; Klasse PJ; Moore JP J Virol; 2015 Dec; 89(23):12189-210. PubMed ID: 26311893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]